Allogene Therapeutics
ALLO
ALLO
181 hedge funds and large institutions have $2.25B invested in Allogene Therapeutics in 2021 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 82 increasing their positions, 29 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
1.83% less ownership
Funds ownership: 62.83% → 61% (-1.8%)
28% less capital invested
Capital invested by funds: $3.12B → $2.25B (-$868M)
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
Holders
181
Holding in Top 10
3
Calls
$4.69M
Puts
$4.68M
Top Buyers
| 1 | +$59.2M | |
| 2 | +$27M | |
| 3 | +$19.6M | |
| 4 |
SC
Sessa Capital
New York
|
+$19.6M |
| 5 |
Renaissance Technologies
New York
|
+$18.4M |
Top Sellers
| 1 | -$189M | |
| 2 | -$80.2M | |
| 3 | -$40.4M | |
| 4 |
ROTUOC
Regents of the University of California
Oakland,
California
|
-$23.9M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
-$23.2M |